CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mingyuan Medicare Development Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mingyuan Medicare Development Co., Ltd.
Room 1801-03, Hutchison House,
10 Harcourt Road, Central
Phone: +852 31023201p:+852 31023201 Hong Kong Fax: +852 31020905f:+852 31020905

This company is no longer actively traded on any major stock exchange.

Business Summary
Mingyuan Medicare Development Company Limited is a Hong Kong-based investment holding company principally engaged in the provision of healthcare solutions. The Company operates through five divisions. Protein Chips division is engaged in the manufacture and distribution of C-12 products. Health Care division is engaged in the sales and marketing of cervical diseases-related products. Medical Centers Management division is engaged in the provision of healthcare services. Individualized Target Therapy division is engaged in the development of specialized molecular diagnostic kits for leukemia, lymphoma and individualized target cancer therapy. Bio-drugs division is engaged in the development and production of a new generation of non-specific nanotechnology immunomodulatory drugs.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201912/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Ping CheungLam 67 5/20/2016 5/20/2016
Chief Executive Officer Sing HungLam 64 12/1/2017 12/1/2017
Executive Director Yip WingHui 69 5/20/2016 5/20/2016
5 additional Officers and Directors records available in full report.

Business Names
Business Name
233
Genetel BVI
Mingyuan Medicare Development Co., Ltd.
Shanghai Ming Yuan Holdings Ltd
Shanghai Yuanqi
Sing Tao Holdings Ltd

General Information
Number of Employees: 1,165 (As of 6/30/2014)
Outstanding Shares: 4,383,892,800 (As of 6/30/2019)
Stock Exchange: HKG
Fax Number: +852 31020905


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023